More on ARWR
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $74.41 |
|
|||
| Open | $74.53 | ||||
| 52 Wk High | $8.22 | ||||
| 52 Wk Low | $3.07 | ||||
| Day High | $75.45 | ||||
| Day Low | $73.29 | ||||
| P/E | N/A | ||||
| EPS | $-1.30 | ||||
| Volume | 1,182,203 | ||||
- Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events
- Arrowhead presents obesity drug data showing liver fat reduction
- Arrowhead Pharmaceuticals Presents New Clinical Data on RNAi-based Obesity and MASH Candidate ARO-INHBE at EASL 2026
- Arrowhead presents plozasiran data supporting use without dose adjustment
- Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress
- Form 144/A ARROWHEAD PHARMACEUTICAL Filed by: Apel Daniel Joseph
- Form 144/A ARROWHEAD PHARMACEUTICAL Filed by: Lu Hongbo
- Form 144/A ARROWHEAD PHARMACEUTICAL Filed by: Hamilton James C
- Form 4 ARROWHEAD PHARMACEUTICAL For: May 12 Filed by: Lu Hongbo
- Arrowhead Pharma (ARWR) PT Raised to $46 at Bernstein SocGen Group
Entities mentioned with ARWR
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Show More...
